Postpartum Continuous Glucose Monitoring for Type 2 Diabetes Mellitus Risk Evaluation in Patients With Gestational Diabetes Mellitus: POSTPOD Trial

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of California, Los Angeles
Study ID
NCT07449039
Status
Recruiting

Conditions

  • Gestational Diabetes Mellitus in Pregnancy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Continuous Glucose Monistor — DEVICE
    Continuous glucose monitoring sensor that provides 24/7 detailed glycemic information. Participants will wear for 24 hours and then be instructed to peel off.

Study Details

This is a pilot study designed to evaluate the effectiveness of continuous glucose monitoring (CGM) within hours of delivery to predict long-term risk of Type 2 Diabetes Mellitus in patients diagnosed with gestational diabetes. Participants will be provided a CGM within 2 hours after delivery and wear the device for 24 hours. Participants will be instructed to peel off the device after 24 hours. Participants will also be asked to complete two surveys regarding their experience at 1-3 months postpartum and 12-14 months postpartum.

Key Dates

Start date
Sep 28, 2025
Status verified
Feb 2026
Primary completion
Dec 31, 2029
Completion
Jun 30, 2030

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Continuous Glucose Monitor
    Administration of a Continuous Glucose Monitor within 2 hours after delivery for 24-hour collection of glycemic data.

Primary Outcome Measure

Clinical Efficacy Associated with CGM use immediately postpartum as compared to the 2 hr Glucose tolerance test [ Time Frame: 24 hours postpartum and 1-3 months postpartum ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, Los AngelesLos AngelesCalifornia90095
Dana Levin-Lopez, MPH
310-794-8893

Find similar trials in Los Angeles, CA

Related Studies